# The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

> **NCT05630651** · NA · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 6 (estimated)

## Conditions studied

- Hemophilia B

## Interventions

- **GENETIC:** ZS801

## Key facts

- **NCT ID:** NCT05630651
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-19
- **Primary completion:** 2025-12
- **Final completion:** 2028-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05630651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05630651, "The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05630651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*